×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Videos
Maps
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Vertex Pharma bets on kidney disease treatment with $4.9 bln Alpine Immune deal
Reuters
Vertex Pharmaceuticals will buy Alpine Immune Sciences for about $4.9 billion in cash, gaining access to the biotech firm's treatment for an...
3 weeks ago
BMS, Repertoire Immune Medicines Enter Strategic Autoimmune Vax Pact
Contract Pharma
Leverages Repertoire's DECODE platform to develop T cell targeted immune medicines.
4 days ago
Vertex Pharma’s takeover of Alpine Immune is a strategic fit: analysts
MarketWatch
Vertex Pharmaceuticals Inc.'s $4.9 billion acquisition of Alpine Immune Sciences Inc. makes strategic sense and will bolster the company's...
3 weeks ago
At Core of Purdue Pharma Case: Who Can Get Immunity in Settlements?
The New York Times
At Core of Purdue Pharma Case: Who Can Get Immunity in Settlements? A broad ruling by the Supreme Court could mean the end of a strategy for...
5 months ago
Immunity Pharma gears up for pivotal trial with ALS drug
Clinical Trials Arena
The Phase IIa results of IPL344 gives the company confidence to progress to a pivotal trial of the candidate in ALS.
3 months ago
US opioid activists argue against Sackler family immunity in Purdue Pharma deal
The Guardian
The US supreme court will hear oral arguments on Monday on whether members of the wealthy Sackler family can receive immunity from civil...
4 months ago
MaaT Pharma indicates completion of Patient Recruitment for the Phase 2a Investigator-Sponsored Randomized ...
Yahoo Finance
Last patient randomized in Phase 2a PICASSO trial, sponsored by AP-HP in collaboration with MaaT Pharma, INRAE and Institut Gustave Roussy,...
1 month ago
Vertex Pharma stock upgraded at Evercore on Alpine Immune deal (NASDAQ:ALPN)
Seeking Alpha
Evercore ISI upgrades Vertex Pharmaceuticals (VRTX) stock on its decision to acquire immunotherapy developer Alpine Immune Sciences (ALPN).
3 weeks ago
Invivyd's COVID prophylactic scores FDA emergency nod for people with weakened immune systems
Fierce Pharma
The FDA endorsed the therapy after Invivyd ran an immunobridging study to show that patients who received Pemgarda had serum-neutralizing...
1 month ago
Taming the Immune System When Rare Diseases Strike
Genetic Engineering and Biotechnology News
Therapies for rare autoimmune diseases are progressing with an enhanced understanding of how the immune system misfires to cause cell,...
2 months ago